Roadmap to cure multiple myeloma

Area of Science:

• Hematology
• Oncology
• Cancer Research

Background:

• Multiple myeloma treatment has advanced, improving response and survival rates.
• Despite progress, relapse and lack of cure remain significant challenges for patients.

Purpose of the Study:

• To propose a five-strategy roadmap for achieving a cure for multiple myeloma.
• To outline a research agenda focusing on novel therapeutic targets and treatment paradigms.

Main Methods:

• Reviewing current knowledge on multiple myeloma pathogenesis, including circulating tumor cells and minimal residual disease (MRD) clones.
• Defining undetectable MRD as a new therapeutic endpoint using high-sensitivity techniques.
• Exploring early detection and intervention strategies for high-risk smoldering myeloma.
• Investigating the use of highly active treatment regimens in standard-risk patients.
• Examining experimental therapies for newly diagnosed high-risk multiple myeloma with early rescue interventions.

Main Results:

• Increased understanding of disease pathogenesis, particularly the role of circulating tumor cells and MRD clones.
• Establishment of undetectable MRD as a key therapeutic goal.
• Potential for early intervention in high-risk smoldering myeloma to delay progression and improve cure rates.
• Identification of optimal treatment strategies for both standard-risk and high-risk newly diagnosed patients.

Conclusions:

• A multi-pronged strategy focusing on deeper biological insights, novel endpoints, and timely interventions is crucial for multiple myeloma cure.
• Early detection and treatment of high-risk precursor conditions may significantly improve long-term outcomes.
• Eradicating all tumor clones to achieve sustained MRD negativity is the ultimate goal for a cure.